It has been stated that TIPE2 mRNA expression was substantially declined in individuals with SLE in contrast to healthy individuals and was negatively correlated with the SLE disease activity index (SLEDAI) and myxoma resistance protein 1 (MX1) mRNA expression levels in SLE participants [17]. This evidence concerns the gene TIPE2 and systemic lupus erythematosus.